SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-012439
Filing Date
2023-04-11
Accepted
2023-04-11 16:06:19
Documents
12
Period of Report
2023-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ubx-20230410.htm   iXBRL 8-K 48418
  Complete submission text file 0000950170-23-012439.txt   165488

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ubx-20230410.xsd EX-101.SCH 2484
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ubx-20230410_pre.xml EX-101.PRE 9851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ubx-20230410_lab.xml EX-101.LAB 13350
6 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20230410_htm.xml XML 4715
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 23813469
SIC: 2834 Pharmaceutical Preparations